Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients.

Gabriele Negro,Antonio Boccellino,Antonio Napolano,Emanuele Micaglio,Zarko Calovic,Luigi Anastasia,Giuseppe Ciconte

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology（2023）

引用 0|浏览7

暂无评分

摘要

RFA can be considered as a therapeutic option in symptomatic BrS patients with a high-risk profile who cannot discontinue TRT, being essential for restoring their normal physiology or preserving their sexual identity. As testosterone use is increasing, further studies are warranted to define a standardized diagnostic and therapeutic strategy in this specific subset of BrS patients.

查看译文

关键词

Brugada syndrome, Testosterone therapy, Radiofrequency ablation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要